Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which wil ...

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

As Wall Street’s broader market averages continue to decline on Tuesday, following Monday’s significant sell-off, the idea of ...

As layoffs continue to strike biopharma outfits big and small, life sciences technology and service provider Cytiva is ...

Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

We recently compiled a list of the 15 Best S&P 500 Dividend Stocks to Buy Now. In this article, we are going to take a look ...

The collaboration has already yielded strong results, including the in-licensing of EVT8683 (now BMS-986419) by Bristol Myers Squibb in September 2021. In March 2023, the companies reaffirmed their ...